Print version Send to a friend
Contact Sitemap
Search
Go..
Press kit
Press Relese ERS Sept 2004
Respimat® Soft Mist™ Inhaler (SMI) represents a major step forward in inhalation therapy, resulting in high patient preference and satisfaction over other devices, according to the results of an analysis presented on Sunday, September 5, 2004 in the thematic poster session "Primary Care: COPD" at the 14th Annual Congress of the European Respiratory Society in Glasgow, United Kingdom.
Full text
Need for new inhaler
Respimat® Soft Mist™ Inhaler: The need for a new inhaler device. The clinical success of a medication depends upon its efficacy, tolerability and, since compliance is a significant issue, its acceptability to patients.
Full text
New generation inhaler
Boehringer Ingelheim, with its experience in modern device technology coupled with extensive experience in the development of respiratory drugs, takes a significant step forward for inhaler therapy by launching the first Respimat® product, Berodual® Respimat®, in Germany in early 2004.
Full text
Technical background
Respimat® Soft Mist™ Inhaler (SMI), developed by Boehringer Ingelheim, is a propellant-free, new generation inhaler that represents a major step forward in inhalation therapy.
Full text
Boehringer's COPD activities
COPD is a major socio-economic burden, being among the top 5 causes of disability and death in industrial societies. In spite of its enormous burden to societies and the individual, and although there are potentially more COPD patients than asthma patients, COPD is widely under-diagnosed and mistreated for a variety of reasons.
Full text
Glossary
Full text
Respimat® Insight – the new generation inhaler
How to use
Twist, press and breathe – it's that easy to use the Respimat® Soft Mist™ Inhaler.